A randomized clinical trial of hospital-based, comprehensive cardiac rehabilitation versus usual care for patients with congestive heart failure, ischemic heart disease or high risk of ischemic heart disease (the DANREHAB Trial) – design, intervention and population.

Anne Dorthe Zwisler, Lone Helle Schou, Anne M. Soja, Henrik Brønnum-Hansen, Christian Gluud, Lars Iversen, Bjarne Sigurd, Mette Madsen, Jørgen Fischer-Hansen

    Publikation: Bidrag til tidsskriftTidsskriftsartikelForskningpeer review

    Abstract

    Background: Current guidelines broadly recommend comprehensive cardiac rehabilitation (CR), although evidence for this is still limited. It is not known whether evidence from before 1995 is still valid. Study Design: The DANish Cardiac ReHABilitation (DANREHAB) trial was designed as a centrally randomized clinical trial to clarify whether hospital-based comprehensive CR is superior to usual care for patients with congestive heart failure, ischemic heart disease, or high risk for ischemic heart disease. A combined primary outcome measure included total mortality, myocardial infarction, or readmissions due to heart disease based on linkage to public registries. The CR was an individually tailored, multidisciplinary program (6 weeks of intensive CR and 12 months of follow-up) including patient education, exercise training, dietary counseling, smoking cessation, psychosocial support, risk factor management, and clinical assessment. Study Population: Of 5060 discharged patients, 1614 (32%) were eligible for the trial and 770 patients were randomized (47% of those eligible). Participants were younger (P < .001) and had less comorbidity than nonparticipants (P < .03). Conclusion: Our trial shows that a large-scale, centrally randomized clinical trial on comprehensive CR can be conducted among a broadly defined patient group, but reaching the stipulated number of 1800 patients was difficult. Although the study included relatively many women and older people, elderly patients and patients with high comorbidity were underrepresented, which may influence the external validity.

    OriginalsprogEngelsk
    TidsskriftAmerican Heart Journal
    Vol/bind150
    Udgave nummer5
    Sider (fra-til)899.e7-899.e16
    ISSN0002-8703
    DOI
    StatusUdgivet - nov. 2005

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'A randomized clinical trial of hospital-based, comprehensive cardiac rehabilitation versus usual care for patients with congestive heart failure, ischemic heart disease or high risk of ischemic heart disease (the DANREHAB Trial) – design, intervention and population.'. Sammen danner de et unikt fingeraftryk.

    Citationsformater